top of page
Insights
B4PF1.0 and B4PF2.0
Three Lakes 12-20 is driven to develop therapies that will prevent and ultimately cure PF. To do this, it is essential to study the...
The Idiopathic Pulmonary Fibrosis (IPF) Cell Atlas
www.ipfcellatlas.com Funding from Three Lakes Foundation was instrumental in the generation of the IPF Cell Atlas. The IPF Cell Atlas...
Telomere Trial
Telomere shortening has been linked to a worse prognosis for patients with PF. Additional of thymidine to cell lines or to stem cells...
bottom of page